New hope for painful skin condition: drug trial targets HS Flare-Ups

NCT ID NCT06118099

Terminated Disease control Sponsor: Sanofi Source: ClinicalTrials.gov ↗

First seen Nov 06, 2025 · Last updated May 15, 2026 · Updated 18 times

Summary

This study tested a drug called amlitelimab in 90 adults aged 18-70 with moderate to severe hidradenitis suppurativa (HS), a painful skin condition causing boils and tunnels. The goal was to see if the drug reduces skin abscesses and inflammation better than a placebo over 16 weeks. Participants could continue treatment for up to 80 more weeks to check long-term safety and effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Beth Israel Deaconess Medical Center Site Number : 8400006

Boston, Massachusetts, 02215, United States
Center for Clinical Studies, LTD. LLP Site Number : 8400001

Houston, Texas, 77004, United States
Center for Dermatology Clinical Research Site Number : 8400010

Fremont, California, 94538-1614, United States
Centricity Research Site Number : 8400009

Dublin, Ohio, 43016, United States
Clinical Partners, LLC Site Number : 8400003

Johnston, Rhode Island, 02919, United States
Corazon USA, LLC (DBA Life Clinical Trials) Site Number : 8400011

Margate, Florida, 33063, United States
Florida International Research Center Site Number : 8400016

Miami, Florida, 33173, United States
Investigational Site Number : 0360001

Darlinghurst, New South Wales, 2010, Australia
Investigational Site Number : 0360002

Melbourne, Victoria, 3004, Australia
Investigational Site Number : 0360003

Phillip, Australian Capital Territory, 2606, Australia
Investigational Site Number : 1240001

Québec, G1W 4R4, Canada
Investigational Site Number : 1240002

Hamilton, Ontario, L8L 3C3, Canada
Investigational Site Number : 1240007

Barrie, Ontario, L4M 7G1, Canada
Investigational Site Number : 1520001

Santiago, Reg Metropolitana de Santiago, 7640881, Chile
Investigational Site Number : 1520002

Santiago, Reg Metropolitana de Santiago, 8380465, Chile
Investigational Site Number : 1520003

Santiago, Reg Metropolitana de Santiago, 7580206, Chile
Investigational Site Number : 2500001

Reims, 51100, France
Investigational Site Number : 2500002

Saint-Mandé, 94163, France
Investigational Site Number : 2500003

Lyon, 69003, France
Investigational Site Number : 2500004

Rouen, 76031, France
Investigational Site Number : 2500005

La Rochelle, 17019, France
Investigational Site Number : 2760001

Münster, 48149, Germany
Investigational Site Number : 2760002

Bochum, 44791, Germany
Investigational Site Number : 3480001

Debrecen, 4032, Hungary
Investigational Site Number : 3480002

Szeged, 6720, Hungary
Investigational Site Number : 3480004

Budapest, 1083, Hungary
Investigational Site Number : 3800001

Catania, 95123, Italy
Investigational Site Number : 3800002

Cona (Ferrara), 44124, Italy
Investigational Site Number : 6160001

Warsaw, Masovian Voivodeship, 02-507, Poland
Investigational Site Number : 6160003

Wroclaw, 50-566, Poland
Investigational Site Number : 6160004

Warsaw, 02-962, Poland
Investigational Site Number : 6200001

Lisbon, 1998-018, Portugal
Investigational Site Number : 6200002

Lisbon, 1649-035, Portugal
Investigational Site Number : 7240001

Barcelona, Barcelona [Barcelona], 08041, Spain
Investigational Site Number : 7240002

Madrid, Madrid, Comunidad de, 28046, Spain
Investigational Site Number : 7240003

Badalona, Catalunya [Cataluña], 08916, Spain
Investigational Site Number : 7240006

Las Palmas de Gran Canaria, Las Palmas, 35010, Spain
Medical Dermatology Specialists Site Number : 8400002

Phoenix, Arizona, 85006-2754, United States
Stryde Research Epiphany Dermatology Site Number : 8400014

Southlake, Texas, 76092, United States
University of South Florida Site Number : 8400012

Tampa, Florida, 33612, United States
Vast Skin Specialists Site Number : 8400015

Addison, Texas, 75001, United States
Washington University School of Medicine Site Number : 8400007

St Louis, Missouri, 63110, United States

Conditions

Explore the condition pages connected to this study.

HIDRADENITIS